![](/img/cover-not-exists.png)
Cell panel profiling of pre-clinical and clinical anti-cancer agents reveals conserved therapeutic clusters and differentiates the mechanism of action of different PI3K/mTOR, Aurora kinase and EZH2 inhibitors
Uitdehaag, J.C.M., De Roos, J.A.D.M., Prinsen, M.B.W., Willemsen-Seegers, N., De Vetter, J.R.F., Dylus, J., Van Doornmalen, A.M., Kooijman, J., Sawa, M., Van Gerwen, S.J.C., De Man, J., Buijsman, R.C.Volume:
69
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/s0959-8049(16)32652-1
Date:
December, 2016
File:
PDF, 51 KB
english, 2016